Tofacitinib as a Treatment for Refractory Dermatomyositis: A Case Report

Journals Menu

Articles
Archive
Indexing
Aims & Scope
Editorial Board
For Authors
Publication Fees

Open Special Issues
Published Special Issues
Special Issues Guideline

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Open Journal of Rheumatology and Autoimmune Diseases

ISSN Print: 2163-9914
ISSN Online: 2164-005X
www.scirp.org/journal/ojra
E-mail: ojra@scirp.org

Citations

Journals Menu

Articles
Archive
Indexing
Aims & Scope
Editorial Board
For Authors
Publication Fees

"Tofacitinib as a Treatment for Refractory Dermatomyositis: A Case Report"
written by Samuel Katsuyuki Shinjo, Fernando Henrique Carlos de Souza,
published by Open Journal of Rheumatology and Autoimmune Diseases, Vol.10 No.1, 2020

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Use of JAK Inhibitors in Dermatomyositis: A Systematic Literature Review
	Clinical and …, 2023

[2]	Up-to-date treatment and management of myositis
	2020

Most cited
Most downloaded
E-Mail Alert
OJRA Subscription
Publication Ethics & OA Statement
Frequently Asked Questions
Recommend to Peers
Recommend to Library
Contact us
Disclaimer
History Issue

Open Special Issues
Published Special Issues
Special Issues Guideline

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Open Journal of Rheumatology and Autoimmune Diseases

Open Journal of Rheumatology and Autoimmune Diseases

Journals Menu

Home

About SCIRP

Service

Policies

[1]	Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisons Expert Opinion on Pharmacotherapy, 2024 DOI:10.1080/14656566.2024.2392021

[2]	Up-to-date treatment and management of myositis Current Opinion in Rheumatology, 2020 DOI:10.1097/BOR.0000000000000745